BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38457959)

  • 1. A comparison between centralized and asynchronous federated learning approaches for survival outcome prediction using clinical and PET data from non-small cell lung cancer patients.
    Vo VT; Shin TH; Yang HJ; Kang SR; Kim SH
    Comput Methods Programs Biomed; 2024 May; 248():108104. PubMed ID: 38457959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decentralized collaborative multi-institutional PET attenuation and scatter correction using federated deep learning.
    Shiri I; Vafaei Sadr A; Akhavan A; Salimi Y; Sanaat A; Amini M; Razeghi B; Saberi A; Arabi H; Ferdowsi S; Voloshynovskiy S; Gündüz D; Rahmim A; Zaidi H
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1034-1050. PubMed ID: 36508026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting treatment response in multicenter non-small cell lung cancer patients based on federated learning.
    Liu Y; Huang J; Chen JC; Chen W; Pan Y; Qiu J
    BMC Cancer; 2024 Jun; 24(1):688. PubMed ID: 38840081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning model integrating positron emission tomography and clinical data for prognosis prediction in non-small cell lung cancer patients.
    Oh S; Kang SR; Oh IJ; Kim MS
    BMC Bioinformatics; 2023 Feb; 24(1):39. PubMed ID: 36747153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-institutional PET/CT image segmentation using federated deep transformer learning.
    Shiri I; Razeghi B; Vafaei Sadr A; Amini M; Salimi Y; Ferdowsi S; Boor P; Gündüz D; Voloshynovskiy S; Zaidi H
    Comput Methods Programs Biomed; 2023 Oct; 240():107706. PubMed ID: 37506602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An [
    Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
    Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
    Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
    Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel analytical approach for outcome prediction in newly diagnosed NSCLC based on [
    Zhang L; Xu C; Zhang X; Wang J; Jiang H; Chen J; Zhang H
    Eur Radiol; 2023 Mar; 33(3):1757-1768. PubMed ID: 36222865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decentralized Distributed Multi-institutional PET Image Segmentation Using a Federated Deep Learning Framework.
    Shiri I; Vafaei Sadr A; Amini M; Salimi Y; Sanaat A; Akhavanallaf A; Razeghi B; Ferdowsi S; Saberi A; Arabi H; Becker M; Voloshynovskiy S; Gündüz D; Rahmim A; Zaidi H
    Clin Nucl Med; 2022 Jul; 47(7):606-617. PubMed ID: 35442222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and
    Ju H; Kim K; Kim BI; Woo SK
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of mediastinal lymph node metastasis based on
    Yin G; Song Y; Li X; Zhu L; Su Q; Dai D; Xu W
    Eur Radiol; 2021 Jun; 31(6):3983-3992. PubMed ID: 33201286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.
    Pfaehler E; Mesotten L; Zhovannik I; Pieplenbosch S; Thomeer M; Vanhove K; Adriaensens P; Boellaard R
    Med Phys; 2021 Mar; 48(3):1226-1238. PubMed ID: 33368399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential privacy preserved federated transfer learning for multi-institutional
    Shiri I; Salimi Y; Maghsudi M; Jenabi E; Harsini S; Razeghi B; Mostafaei S; Hajianfar G; Sanaat A; Jafari E; Samimi R; Khateri M; Sheikhzadeh P; Geramifar P; Dadgar H; Bitrafan Rajabi A; Assadi M; Bénard F; Vafaei Sadr A; Voloshynovskiy S; Mainta I; Uribe C; Rahmim A; Zaidi H
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):40-53. PubMed ID: 37682303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
    Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
    PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?
    Konert T; Everitt S; La Fontaine MD; van de Kamer JB; MacManus MP; Vogel WV; Callahan J; Sonke JJ
    PLoS One; 2020; 15(2):e0228793. PubMed ID: 32097418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of A Nomogram Prediction Model for PD-L1 Expression 
in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters].
    Hao L; Wang L; Zhang M; Yan J; Zhang F
    Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):833-842. PubMed ID: 38061885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer.
    Pellegrino S; Fonti R; Mazziotti E; Piccin L; Mozzillo E; Damiano V; Matano E; De Placido S; Del Vecchio S
    Ann Nucl Med; 2019 Dec; 33(12):937-944. PubMed ID: 31612416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a feasibility study.
    Dimitrakopoulou-Strauss A; Hoffmann M; Bergner R; Uppenkamp M; Eisenhut M; Pan L; Haberkorn U; Strauss LG
    Mol Imaging Biol; 2007; 9(5):308-17. PubMed ID: 17623254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.